ASIM Joins Coalition in Effort to Bring Tobacco Industry Under FDA Control

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 3
Volume 4
Issue 3

WASHINGTON--The American Society of Internal Medicine (ASIM) joined the Coalition on Smoking OR Health in its effort to create FDA oversight of the tobacco industry. ASIM's policy on tobacco supports stronger cigarette labels,

WASHINGTON--The American Society of Internal Medicine (ASIM) joinedthe Coalition on Smoking OR Health in its effort to create FDAoversight of the tobacco industry. ASIM's policy on tobacco supportsstronger cigarette labels, increasing the legal age to buy tobaccoproducts to 21, and a ban on tobacco advertising or at least eliminationof its tax deductibility.

Recent Videos
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Related Content